# S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

> **NCT00049335** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 29 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT00049335
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049335, "S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00049335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*